Rchr
J-GLOBAL ID:201901016209378778   Update date: May. 22, 2024

Kanesaka Manato

Kanesaka Manato
Affiliation and department:
Research field  (1): Urology
Research theme for competitive and other funds  (1):
  • 2020 - 2023 微小環境下の前立腺癌エピゲノム変化に基づく去勢抵抗性獲得機序の解明
Papers (31):
  • Shinpei Saito, Keisuke Ando, Shinichi Sakamoto, Minhui Xu, Yasutaka Yamada, Junryo Rii, Sanji Kanaoka, Jiaxing Wei, Xue Zhao, Sangjon Pae, et al. The LAT1 inhibitor JPH203 suppresses the growth of castration-resistant prostate cancer through a CD24-mediated mechanism. Cancer science. 2024
  • Sanji Kanaoka, Atsushi Okabe, Manato Kanesaka, Bahityar Rahmutulla, Masaki Fukuyo, Motoaki Seki, Takayuki Hoshii, Hiroaki Sato, Yusuke Imamura, Shinichi Sakamoto, et al. Chromatin activation with H3K36me2 and compartment shift in metastatic castration-resistant prostate cancer. Cancer Letters. 2024. 588. 216815-216815
  • Yudai Fukui, Yasutaka Yamada, Shinichi Sakamoto, Takuro Horikoshi, Xue Zhao, Kodai Sato, Sakie Nanba, Yoshihiro Kubota, Manato Kanesaka, Ayumi Fujimoto, et al. Preoperative PI-RADS v2.1 Scoring System Improves Risk Classification in Patients Undergoing Radical Prostatectomy. Anticancer research. 2023. 43. 12. 5705-5712
  • Nobuyoshi Takeuchi, Yusuke Imamura, Kazuki Ishiwata, Manato Kanesaka, Yusuke Goto, Tomokazu Sazuka, Sawako Suzuki, Hisashi Koide, Shinichi Sakamoto, Tomohiko Ichikawa. Cushing's syndrome in pregnancy in which laparoscopic adrenalectomy was safely performed by a retroperitoneal approach. IJU Case Reports. 2023
  • Yasutaka Yamada, Shinichi Sakamoto, Kodai Sato, Shinpei Saito, Manato Kanesaka, Junryo Rii, Koichiro Kurokawa, Daisuke Tachiwaki, Yudai Fukui, Hiroki Shibata, et al. Clinical utility of the prognostic nutritional index in patients with metastatic hormone-sensitive prostate cancer: A retrospective, multicenter, cohort study. The Prostate. 2023
more...
MISC (88):
Professional career (1):
  • 博士(医学) (千葉大学大学院)
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page